The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Self-citationShimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Self-citationLehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
The molecular biology of cytochrome P450s
Gonzalez, F. J. (1988) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00021-3 · Cited by 1,301
Variations on a Theme: Cataloging Human DNA Sequence Variation
Collins, F. S., Guyer, M. S., & Chakravarti, A. (1997) · Science · doi:10.1126/science.278.5343.1580 · Cited by 1,050
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
Halushka, M. K., Fan, J.-B., Bentley, K., Hsie, L., Shen, N., Weder, A., Cooper, R., Lipshutz, R., & Chakravarti, A. (1999) · Nature Genetics · doi:10.1038/10297 · Cited by 1,012
Rendic, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 949
Nickerson, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2745 · Cited by 931
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation: Table 1.
Collins, F. S., Brooks, L. D., & Chakravarti, A. (1998) · Genome Research · doi:10.1101/gr.8.12.1229 · Cited by 824
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Self-citationGoodwin, B., Hodgson, E., & Liddle, C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12400-5 · Cited by 646
When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.
Maquat, L. E. (1995) · Europe PMC (PubMed Central) · Cited by 513
Schuetz, E. G., Beck, W. T., & Schuetz, J. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08713-9 · Cited by 494
Self-citationAoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V, Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81632-5 · Cited by 482
Amirimani, B., Walker, A. H., Weber, B. L., & Rebbeck, T. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1588 · Cited by 465
Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., & Vandenbranden, M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09441-6 · Cited by 402
Self-citationChristopher Gorski, J., Hall, S. D., Jones, D. R., & VandenBranden, M. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90543-6 · Cited by 395
Self-citationModification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J., & Malkowicz, S. B. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1225 · Cited by 360
Kivisto, K., Kroemer, H., & Eichelbaum, M. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05796.x · Cited by 340
Association of CYP 3 A 4 genotype with treatment-related leukemia
Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N.-K. V., Lovett, B. D., Nowell, P. C., Blair, I. A., & Rebbeck, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13176 · Cited by 310
Westlind, A., Löfberg, L., Tindberg, N., Andersson, T. B., & Ingelman-Sundberg, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0752 · Cited by 300
The Regulation of Splice-Site Selection, and Its Role in Human Disease
Cooper, T. A., & Mattox, W. (1997) · The American Journal of Human Genetics · doi:10.1086/514856 · Cited by 278
Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
Schuetz, J. D., Beach, D. L., & Guzelian, P. S. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00002 · Cited by 273
Self-citationThe role of individual human cytochrpmes P450 in drug metabolism and clinical response
Cholerton, S., Daly, A. K., & Idle, J. R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90140-2 · Cited by 246
Self-citationBall, S. E., Scatina, J., Kao, J., Ferron, G. M., Fruncillo, R., Mayer, P., Weinryb, I., Guida, M., Hopkins, P. J., Warner, N., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70037-8 · Cited by 233
Identification of a polymorphically expressed member of the human cytochrome P-450III family.
Wrighton, S. A., Ring, B. J., Watkins, P. B., & VandenBranden, M. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09114-x · Cited by 228
Self-citationHASHIMOTO, H., TOIDE, K., KITAMURA, R., FUJITA, M., TAGAWA, S., ITOH, S., & KAMATAKI, T. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18412.x · Cited by 209
Paris, P. L., Kupelian, P. A., Hall, J., et al. (1999) · PubMed · Cited by 189
Bimodal distribution of renal cytochrome P450 3A activity in humans.
Haehner, B. D., Gorski, J. C., Vandenbranden, M., Wrighton, S. A., Janardan, S. K., Watkins, P. B., & Hall, S. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09155-2 · Cited by 181
Self-citationThe human cytochrome P450 3A locus. Gene evolution by capture of downstream exons
Finta, C., & Zaphiropoulos, P. G. (2000) · Gene · doi:10.1016/s0378-1119(00)00470-4 · Cited by 170
Expression of cytochrome P450 3A in amphibian, rat, and human kidney
Schuetz, E. G., Schuetz, J. D., Grogan, W. M., Náray‐Fejes‐Tóth, A., Fejes‐Tóth, G., Raucy, J. L., Guzelian, P. S., Gionela, K., & Watlington, C. O. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90159-t · Cited by 148
Self-citationGillam, E. M. J., Guo, Z., Ueng, Y., Yamazaki, H., Cock, I. E., Reilly, P. E. B., Hooper, W. D., & Guengerich, F. P. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1177 · Cited by 141
Nebert, D. W. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00001 · Cited by 92
Paulussen, A. D. C., Lavrijsen, K., Bohets, H., Hendrickx, J., Verhasselt, P., Luyten, W. H. M. L., Konings, F., & Armstrong, M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00005 · Cited by 91
Detection of a CYP3A5 Allelic Variant: A Candidate for the Polymorphic Expression of the Protein?
Jounaïdi, Y., Hyrailles, V., Gervot, L., & Maurel, P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0618 · Cited by 80
Self-citation16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5
Huang, Z. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.867 · Cited by 70
Maquat, L. E. (2001) · Nature Genetics · doi:10.1038/83759 · Cited by 47
Fallen arches, or how the vertebrate got its head.
Fishman, M. C., & Kirby, M. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4143 · Cited by 40
Corticosterone 6 beta-hydroxylase in A6 epithelia: a steroid-inducible cytochrome P-450
Grogan, W. M., Phillips, V., Schuetz, E. G., et al. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c480 · Cited by 24
Self-citation
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Metadata
- Authors
- Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, M. S., & Schuetz, E.
- Venue
- Nature Genetics
- Published
- 2001-04
- Volume
- 27
- Issue
- 4
- Pages
- 383-391
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2105902511
- Cited by
- 2,162
- References
- 43
- FWCI
- 76.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.